ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

An 18-Month Comparison of Clinical Outcomes Between Continuous-Flow Left Ventricular Assist Devices

Friday, December 13, 2019

Submitted by

Emily Robinson

Source

Source Name: European Journal of Cardio-Thoracic Surgery

Source URL: https://doi.org/10.1093/ejcts/ezz268

Author(s)

Osnat Itzhaki Ben Zadok, Ben Ben-Avraham, Aviv Shaul, Yoav Hammer, Victor Rubachevski, Dan Aravot, Ran Kornowski, Tuvia Ben-Gal

The authors analyzed the outcomes of the continuous-flow left ventricular assist devices. The study includes 105 patients supported with HM2 (N=54), HM3 (N=25), and HW (N-26). Eighteen-month data suggested that HM3 had a better prognostic and adverse-event profile over other devices.